Search Results - "FONTAO, Karina"

Phase I/II Study of Erlotinib Combined With Cisplatin and Radiotherapy in Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck by Herchenhorn, Daniel, M.D, Dias, Fernando L., M.D., Ph.D, Viegas, Célia M.P., M.D., M.Sc., Ph.D, Federico, Miriam H., M.D., Ph.D, Araújo, Carlos Manoel M., M.D., Ph.D, Small, Isabelle, M.Sc, Bezerra, Marcos, M.D, Fontão, Karina, M.D, Knust, Renata E., R.N, Ferreira, Carlos G., M.D., Ph.D, Martins, Renato G., M.D., M.P.H

“…Purpose Erlotinib, an oral tyrosine kinase inhibitor, is active against head-and-neck squamous cell carcinoma (HNSCC) and possibly has a synergistic…”
Get full text

Phase I Trial of Erlotinib Combined with Cisplatin and Radiotherapy for Patients with Locally Advanced Cervical Squamous Cell Cancer by NOGUEIRA-RODRIGUES, Angélica, DO CARMO, Claudio C, SMALL, Isabele A, FERREIRA, Carlos G, VIEGAS, Célia, ERLICH, Felipe, CAMISAO, Claudia, FONTAO, Karina, LIMA, Roberta, HERCHENHORN, Daniel, MARTINS, Renato G, MORALEZ, Giulliana M

“…Purpose: This phase I trial was aimed to determine the maximum tolerated dose and related toxicity of erlotinib (E) when administered concurrently with…”
Get full text